The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Bio Manufacturing of the Future requires cost effective, scalable solutions that can be implemented quicker than the traditional stainless steel facilities of yesterday. This session explores aspects of bio manufacturing that challenge the status quo and push the boundaries of bio manufacturing as we know it. From continuous methodologies to disposable technologies, we explore the industries response to the bio manufacturing capacity challenge.
Session Leader(s):
Tara
Tibbs,
Sr Director Engineering API/DP,
Eli Lilly & Co
Speaker(s):
Scott
Keetch,
Vice President Strategic Program Management Lead - BioTech,
Bayer
Robert
K. Allen,
Executive Technical Director |Advanced Technologies & Life Sciences,
Fluor Life Sciences
Jon
Van Pelt,
Vice President/General Manager - BioProcess Single Use and Enterprise,
Cytiva